UVA Health is launching a $30 million, multisite clinical trial to determine if the powerful anesthetic ketamine can save patients from prolonged, life-threatening grand mal epilepsy seizures that won ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback